Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma (original) (raw)

2004, World journal of gastroenterology : WJG

Abstract

AIM: Only a minority of patients carrying a defined viral aetiologic agent develop cirrhosis and ultimately hepatocellular carcinoma (HCC), the mechanism underlying the worsening is still undefined. Experimental infection by Helicobacter hepaticus in mice causes chronic hepatitis and HCC and recently, more Helicobacter species (Helicobacter spp.) have been detected in the liver of patients suffering from cholestatic diseases and HCC arising from non-cirrhotic liver. We investigated whether Helicobacter spp. sequences could be detected in the liver of patients with cirrhosis and HCC compared to subjects with metastasis to liver from colon cancer.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (30)

  1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide inci- dence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-841
  2. Sherlock S, Dooley J. Diseases of the liver and biliary system. 10 th Edition. Oxford: Blackwell Scientific Publications 1997
  3. Maio G, D'Argenio P, Stroffolini T, Bozza A, Sacco L, Tosti ME, Intorcia M, Fossi E, D'Alessio G, Anesti Kondili A, Rapicetta M. Mele A and the collaborating group. Hepatitis C virus infection and alanine transaminase levels in the general population: a sur- vey in a southern Italian town. J Hepatol 2000; 33: 116-120
  4. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Foca A, Piazza M. Prevalence, risk factors, and geno- type distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997; 26: 1006-1011
  5. Silini E, Bottelli R, Asti M, Bruno S, Candusso ME, Brambilla S, Bono F, Iamoni G, Tinelli C, Mondelli MU, Ideo G. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterology 1996; 111: 199-205
  6. Wiese M, Berr F, Lafrenz M, Porst H, Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 2000; 32: 91-96
  7. Peano G, Menardi G, Ponzetto A, Fenoglio L. HLA-DR5. A ge- netic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med 1994; 154: 2733-2736
  8. Cassell GH. Infectious causes of chronic inflammatory diseases and cancer. Emerging Infect Dis 1998; 4: 475-487
  9. Mosnier JF, Scoazec JY, Marcellin P, Degott C, Behhamou JP, Feldmann G. Expression of cytokine-dependent immune adhe- sion molecules by hepatocytes and bile duct cells in chronic hepa- titis C. Gastroenterology 1994; 107: 1457-1468
  10. Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ, Gorelick PL, Nagashima K, Gonda MA, Gilden RV, Tully JG, Russell RJ, Benveniste RE, Paster BJ, Dewhirst FE, Donovan JC, Anderson LM, Rice JM. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 1994; 86: 1222-1227
  11. Bulent K, Murat A, Esin A, Fatih K, MMMurat H, Hakan H, Melih K, Mehmet A, Bulent Y, Fatih H. Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish population. World J Gastroenterol 2003; 9: 1580-1583
  12. Palmas F, Pellicano R, Massimetti E, Berrutti M, Fagoonee S, Rizzetto M. Eradication of Helicobacter pylori infection with pro- ton pump inhibitor-based triple therapy. A randomised study. Panminerva Med 2002; 44: 145-147
  13. Testino G, Cornaggia M, De Iaco F. Helicobacter pylori influence on gastric acid secretion in duodenal ulcer patients diagnosed for the first time. Panminerva Med 2002; 44: 19-22
  14. Li S, Lu AP, Zhang L, Li YD. Anti-Helicobacter pylori immuno- globulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H pylori infection in patients with precancerous lesions. World J Gastroenterol 2003; 9: 755-758
  15. Roussos A, Philippou N, Gourgoulianis KI. Helicobacter pylori infection and respiratory diseases: a review. World J Gastroenterol 2003; 9: 5-8
  16. Yakoob J, Jafri W, Abid S. Helicobacter pylori infection and micro- nutrient deficiencies.World J Gastroenterol 2003; 9: 2137-2139
  17. Nilsson H, Taneera J, Castedal M, Glatz E, Olsson R, Wadstrom T. Identification of Helicobacter pylori and Helicobacter species by PCR, hybridization and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 2000; 38: 1072-1076
  18. Avenaud P, Marais A, Monteiro L, Lebail B, Bioulac Sage P, Balabaud C, Mégraud F. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Can- cer 2000; 89: 1431-1439
  19. Ponzetto A, Pellicano R, Leone N, Cutufia MA, Turrini F, Grigioni WF, D'Errico A, Mortimer P, Rizzetto M, Silengo L. Helicobacter pylori infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypotheses 2000; 54: 275-277
  20. Ishak KG, Anthony PP, Sobin LH. Histological typing of tumors of the liver. World Health Organization. New York : Springer Verlag 1994
  21. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N, Rappuoli R. Molecu- lar characterization of the 128 kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A 1993; 90: 5791-5795
  22. Sun HC, Tang ZY. Preventive treatments for recurrence after cura- tive resection of hepatocellular carcinoma-A literature review of randomized control trials. World J Gastroenterol 2003; 9: 635-640
  23. Fagoonee S, Pellicano R, Rizzetto M, Ponzetto A. The journey from hepatitis to hepatocellular carcinoma: bridging role of Helicobacter species. Panminerva Med 2001; 43: 279-282
  24. Siringo S, Vaira D, Menegatti M, Piscaglia F, Sofia S, Gaetani M, Miglioli M, Corinaldesi R, Bolondi L. High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci 1997; 42: 2024-2030
  25. Spinzi G, Pellicano R, Minoli G, Terreni N, Cutufia M, Fagoonee S, Rizzetto M, Ponzetto A. Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis: the Como cross- sectional study. Panminerva Med 2001; 43: 85-87
  26. Pellicano R, Leone N, Berrutti M, Cutufia MA, Fiorentino M, Rizzetto M, Ponzetto A. Helicobacter pylori seroprevalence in hepa- titis C virus positive patients with cirrhosis. J Hepatol 2000; 33: 648-650
  27. Chen JJ, Chang-Chien CS, Tai DI, Chiou SS, Lee CM, Kuo CH. Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. Dig Dis Sci 1994; 39: 1565-1568
  28. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545
  29. Crabtree J. Cytokine responses to Helicobacter pylori -induced infection. In: Riecken EO, Zeitz M, Stallmach A, Heise W editors. Malignancy and chronic inflammation in the gastro-intestinal tract: new concepts. Lancaster: Kluwer Academic Publishers 1995: 25-36
  30. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraument JF Jr, Rabkin CS. Interleukin-1 polymor- phisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402